A five-year follow-up study on the pathological changes of gastric mucosa after H. pylori eradication.
Chin Med J (Engl). 2003 Jan; 116(1):11-4.CM
To investigate the relationship between H. pylori infection, gastric cancer and other gastric diseases through the changes in gastric mucosa and the status of different gastric diseases within 5 years after H. pylori eradication in H. pylori-positive subjects in a high incidence region of gastric cancer.
One thousand and six adults were selected from the general population in Yantai, Shandong province, a high incidence region for gastric cancer in China. Gastroscopy and Campylobacter-like organism (CLO) testing were performed on all subjects. Biopsy samples from the gastric antrum and body were obtained for histology and assessment of H. pylori infection. All H. pylori-positive subjects were then randomly divided into two groups: treatment group receiving Omeprazole Amoxicillin Clarythromycin (OAC) triple therapy and placebo as controls. These subjects were endoscopically followed up in the second and fifth year. We compared the endoscopic appearance and histology of the biopsy specimens from the same site obtained at the first and last visits.
All 552 H. pylori-positive subjects were randomly and evenly divided into treatment group or control group. During the five-year follow-up, the numbers of patients who continued to be negative or positive for H. pylori were 161 and 198, respectively. Statistical analysis revealed that: (1) At the initial visit, there were no significant differences in the severity and activity of inflammation, atrophy and intestinal metaplasia between the biopsy specimens from the antrum and body respectively in both groups. (2) The severity and activity of inflammation in both the antrum and body were markedly reduced after H. pylori eradication (P = 0.000). (3) Within five years after H. pylori eradication, intestinal metaplasia in the antrum either regressed or had no progression, while the proportion of intestinal metaplasia in the H. pylori-positive group increased significantly (P = 0.032). (4) After H. pylori eradication, the atrophy in both the antrum and body had no significant regression. The P value was 0.223 and 0.402, respectively.
H. pylori eradication results in remarkable reduction in the severity and activity of chronic gastritis, marked resolution of intestinal metaplasia in the antrum. On the other hand, continuous H. pylori infection leads to progressive aggravation of atrophy and intestinal metaplasia.
Zhou L
Department of Gastroenterology, The Third Hospital of Peking University, Beijing 100083, China. zly__zhou@yahoo.com.cn
Sung JJ
Lin S
Jin Z
Ding S
Huang X
Xia Z
Guo H
Chao W
AdultAgedDouble-Blind MethodFollow-Up StudiesGastric MucosaGastritisHelicobacter InfectionsHelicobacter pyloriHumansMetaplasiaMiddle AgedStomach Neoplasms
Zhou, Liya, et al. "A Five-year Follow-up Study On the Pathological Changes of Gastric Mucosa After H. Pylori Eradication." Chinese Medical Journal, vol. 116, no. 1, 2003, pp. 11-4.
Zhou L, Sung JJ, Lin S, et al. A five-year follow-up study on the pathological changes of gastric mucosa after H. pylori eradication. Chin Med J (Engl). 2003;116(1):11-4.
Zhou, L., Sung, J. J., Lin, S., Jin, Z., Ding, S., Huang, X., Xia, Z., Guo, H., Liu, J., & Chao, W. (2003). A five-year follow-up study on the pathological changes of gastric mucosa after H. pylori eradication. Chinese Medical Journal, 116(1), 11-4.
Zhou L, et al. A Five-year Follow-up Study On the Pathological Changes of Gastric Mucosa After H. Pylori Eradication. Chin Med J (Engl). 2003;116(1):11-4. PubMed PMID: 12667379.
TY - JOUR T1 - A five-year follow-up study on the pathological changes of gastric mucosa after H. pylori eradication. AU - Zhou,Liya, AU - Sung,Joseph J Y, AU - Lin,Sanren, AU - Jin,Zhu, AU - Ding,Shigang, AU - Huang,Xuebiao, AU - Xia,Zhiwei, AU - Guo,Huilan, AU - Liu,Jianjun, AU - Chao,William, PY - 2003/4/2/pubmed PY - 2003/4/16/medline PY - 2003/4/2/entrez SP - 11 EP - 4 JF - Chinese medical journal JO - Chin Med J (Engl) VL - 116 IS - 1 N2 - OBJECTIVES: To investigate the relationship between H. pylori infection, gastric cancer and other gastric diseases through the changes in gastric mucosa and the status of different gastric diseases within 5 years after H. pylori eradication in H. pylori-positive subjects in a high incidence region of gastric cancer. METHODS: One thousand and six adults were selected from the general population in Yantai, Shandong province, a high incidence region for gastric cancer in China. Gastroscopy and Campylobacter-like organism (CLO) testing were performed on all subjects. Biopsy samples from the gastric antrum and body were obtained for histology and assessment of H. pylori infection. All H. pylori-positive subjects were then randomly divided into two groups: treatment group receiving Omeprazole Amoxicillin Clarythromycin (OAC) triple therapy and placebo as controls. These subjects were endoscopically followed up in the second and fifth year. We compared the endoscopic appearance and histology of the biopsy specimens from the same site obtained at the first and last visits. RESULTS: All 552 H. pylori-positive subjects were randomly and evenly divided into treatment group or control group. During the five-year follow-up, the numbers of patients who continued to be negative or positive for H. pylori were 161 and 198, respectively. Statistical analysis revealed that: (1) At the initial visit, there were no significant differences in the severity and activity of inflammation, atrophy and intestinal metaplasia between the biopsy specimens from the antrum and body respectively in both groups. (2) The severity and activity of inflammation in both the antrum and body were markedly reduced after H. pylori eradication (P = 0.000). (3) Within five years after H. pylori eradication, intestinal metaplasia in the antrum either regressed or had no progression, while the proportion of intestinal metaplasia in the H. pylori-positive group increased significantly (P = 0.032). (4) After H. pylori eradication, the atrophy in both the antrum and body had no significant regression. The P value was 0.223 and 0.402, respectively. CONCLUSIONS: H. pylori eradication results in remarkable reduction in the severity and activity of chronic gastritis, marked resolution of intestinal metaplasia in the antrum. On the other hand, continuous H. pylori infection leads to progressive aggravation of atrophy and intestinal metaplasia. SN - 0366-6999 UR - https://www.unboundmedicine.com/medline/citation/12667379/A_five_year_follow_up_study_on_the_pathological_changes_of_gastric_mucosa_after_H__pylori_eradication_ DB - PRIME DP - Unbound Medicine ER -
Gastric Mucosa
Helicobacter Infections
Metaplasia
Stomach Neoplasms
[Changes of gastric mucosa histopathology after Helicobacter pylori eradication].
[The assessment of nitric oxide metabolites in gastric juice in Helicobacter pylori infected subjects in compliance with grade of inflammatory lesions in gastric mucosa].
Impact of Helicobacter pylori eradication on the development of MALT, gland atrophy and intestinal metaplasia of the antrum.
[Gastric mucosa lesions in gastric ulcer disease. Initial study and 1-year follow-up after Helicobacter pylori eradication].
Eradication of Helicobacter pylori infection improved gastric mucosal atrophy and prevented progression of intestinal metaplasia, especially in the elderly population: a long-term prospective cohort study.
[Course of histological lesions of the gastric mucosa after eradication of H. pylori in patients with duodenal ulcer. Initial study and 6-month follow-up].
Evaluation of the effects of Helicobacter pylori eradication therapy on gastric antral epithelial hyperproliferation: a prospective six-month follow-up study.
Antral-type mucosa in the gastric incisura, body, and fundus (antralization): a link between Helicobacter pylori infection and intestinal metaplasia?
[Effect of eradication treatment on histological changes of the gastric mucosa in patients with non-ulcer dyspesia and Helicobacter pylori infection. Randomized prospective study].
Is there any relationship between functional dyspepsia and chronic gastritis associated with Helicobacter pylori infection?